DE69133208D1 - Vier-aminosäurenepitop mit schutzwirkung gegen plasmodium vivax malaria - Google Patents

Vier-aminosäurenepitop mit schutzwirkung gegen plasmodium vivax malaria

Info

Publication number
DE69133208D1
DE69133208D1 DE69133208T DE69133208T DE69133208D1 DE 69133208 D1 DE69133208 D1 DE 69133208D1 DE 69133208 T DE69133208 T DE 69133208T DE 69133208 T DE69133208 T DE 69133208T DE 69133208 D1 DE69133208 D1 DE 69133208D1
Authority
DE
Germany
Prior art keywords
epitop
amino acid
protective against
plasmodium vivax
against plasmodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69133208T
Other languages
English (en)
Other versions
DE69133208T2 (de
Inventor
L Hoffman
Yupin Charoenvit
R Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of DE69133208D1 publication Critical patent/DE69133208D1/de
Application granted granted Critical
Publication of DE69133208T2 publication Critical patent/DE69133208T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69133208T 1990-11-06 1991-11-01 Vier-aminosäurenepitop mit schutzwirkung gegen plasmodium vivax malaria Expired - Fee Related DE69133208T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/609,551 US5095093A (en) 1990-11-06 1990-11-06 Protective four amino acid epitope against Plasmodium vivax malaria
PCT/US1991/007940 WO1992007576A1 (en) 1990-11-06 1991-11-01 Protective four amino acid epitope against plasmodium vivax malaria

Publications (2)

Publication Number Publication Date
DE69133208D1 true DE69133208D1 (de) 2003-04-10
DE69133208T2 DE69133208T2 (de) 2003-09-04

Family

ID=24441263

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69133208T Expired - Fee Related DE69133208T2 (de) 1990-11-06 1991-11-01 Vier-aminosäurenepitop mit schutzwirkung gegen plasmodium vivax malaria

Country Status (5)

Country Link
US (2) US5095093A (de)
EP (1) EP0600884B1 (de)
AU (1) AU9125791A (de)
DE (1) DE69133208T2 (de)
WO (1) WO1992007576A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399062B1 (en) * 1990-11-06 2002-06-04 The United States Of America As Represented By The Secretary Of The Navy Murine monoclonal antibody protective against Plasmodium vivax malaria
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030211510A1 (en) * 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20040241750A1 (en) * 2003-03-24 2004-12-02 David Nordman Novel methods for determining the negative control value for multi-analyte assays
US20070110676A1 (en) * 2005-11-17 2007-05-17 The Procter & Gamble Company Compositions useful for prevention and treatment of common cold and influenza-like symptoms
KR101619862B1 (ko) * 2014-09-30 2016-05-12 주식회사 녹십자 간접효소면역측정법을 이용하는 인간 Fc 포함 단백질의 역가 측정키트 및 이를 이용한 Fc 포함 단백질의 역가 측정방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
US4957869A (en) * 1985-07-12 1990-09-18 New York University Immunogenic peptide corresponding to P. vivax CS protein
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
US4997647A (en) * 1987-03-30 1991-03-05 New York University Vaccine against the sporozoite stage of malaria
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it

Also Published As

Publication number Publication date
EP0600884A1 (de) 1994-06-15
EP0600884A4 (de) 1992-12-30
DE69133208T2 (de) 2003-09-04
US5599543A (en) 1997-02-04
AU9125791A (en) 1992-05-26
US5095093A (en) 1992-03-10
WO1992007576A1 (en) 1992-05-14
EP0600884B1 (de) 2003-03-05

Similar Documents

Publication Publication Date Title
DE69321914D1 (de) Antikörper gegen Plasmodium falciparum
TR26551A (tr) Tersine ilgili gradiyanlari olan massedici esya
DE69429314T2 (de) Katheter mit deaktivierbarem seitlichen Eingangsteil
DE69117922D1 (de) Zusammensetzungen gegen malaria
DE69207179D1 (de) Optoelektronisches bauteil
DE69207450D1 (de) Ständer
DE69224637T2 (de) Optoelektronisches bauelement
DE69130313T2 (de) Acrylpolymere
FI950908A0 (fi) Antitussiivi
DE69133208T2 (de) Vier-aminosäurenepitop mit schutzwirkung gegen plasmodium vivax malaria
ATA130190A (de) Fahnenmast
ITGE910041A1 (it) Autogru
ATE204581T1 (de) Organo-eisenkomlexe mit wirkung gegen malaria
DE69122764D1 (de) Arznei gegen hornhautbeschädigungen
AU8442591A (en) Plasmodium vivax and plasmodium knowlesi duffy receptor
DE69123792D1 (de) Hochmolekulare spiropyranverbindung
FI910994A (fi) Mast foer segelfartyg
NO912053L (no) Flaggstang
DE69330280D1 (de) Immuntherapeutika gegen hiv
FI911271A (fi) Framstaellningsfoerfarande foer elledande polymer
DE69224530D1 (de) Badelift
KR930012971U (ko) 승강 장치가 내장된 받침대
BR9101538A (pt) Borne inicial
PT8385T (pt) Balcao expositor
ITMI920416U1 (it) Indumento provvisto di generatore luminoso

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee